| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 05/30/2002 | WO2002042295A2 Peptides as met-ap2 inhibitors |
| 05/30/2002 | WO2002041921A2 Compositions for protection against bovine viral diseases |
| 05/30/2002 | WO2002041920A1 Oral pharmaceutical compositions containing cyclodextrins as taste masking agent |
| 05/30/2002 | WO2002041919A1 Freeze-dried pantoprazole preparation and pantoprazole injection |
| 05/30/2002 | WO2002041915A1 A composition of sodium channel blocking compound |
| 05/30/2002 | WO2002041912A1 Drugs and foods improving the quality of life and process for producing the same |
| 05/30/2002 | WO2002041910A2 Methods and compositions for the treatment of diseases of the eye |
| 05/30/2002 | WO2002041900A1 Preparation for strengthening the immune response in the waldeyer's ring and the oronasal mucosa by intranasal administration |
| 05/30/2002 | WO2002041892A1 Water-soluble liquid internal medicine |
| 05/30/2002 | WO2002041883A2 As-needed administration of tricyclic and other non-sri antidepressant drugs to treat premature ejaculation |
| 05/30/2002 | WO2002041881A2 Repinotan kit |
| 05/30/2002 | WO2002041878A2 Titratable dosage transdermal delivery system |
| 05/30/2002 | WO2002041874A2 Granulation process |
| 05/30/2002 | WO2002041853A1 O/w emulsion composition and method of preparing the same |
| 05/30/2002 | WO2002041847A1 Cosmetic or dermatological agent in the form of a creamy permanent mousse or a stable foamed cream |
| 05/30/2002 | WO2002041844A2 Chemotherapeutic composition using nanocrystalline calcium phosphate paste |
| 05/30/2002 | WO2002041837A2 Treatment of mucositis |
| 05/30/2002 | WO2002018477A3 Elastomeric functional biodegradable copolyester amides and copolyester urethanes |
| 05/30/2002 | WO2002018441A3 Electroprocessed fibrin-based matrices and tissues |
| 05/30/2002 | WO2002016333A3 Thioflavin derivatives and their use in diagnosis and theraphy of alzheimer's disease |
| 05/30/2002 | WO2002008426A3 Fh-binding protein of streptococcus pneumoniae |
| 05/30/2002 | WO2002004034A3 Polymer-bound metal-containing compositions |
| 05/30/2002 | WO2001097778A3 Amphotericin b structured emulsion |
| 05/30/2002 | WO2001095894A3 Topical water-based anti-inflammatory compositions |
| 05/30/2002 | WO2001092580A3 Lyophilizable and enhanced compacted nucleic acids |
| 05/30/2002 | WO2001091724A3 Transdermal delivery of lasofoxifene |
| 05/30/2002 | WO2001087934A3 Treatment of neoplasia/transformation using a pituitary tumor transforming gene carboxy terminal peptides |
| 05/30/2002 | WO2001083520A3 Polyacid glycopeptide derivatives |
| 05/30/2002 | WO2001078683A3 Sustained release formulations comprising growth hormone |
| 05/30/2002 | WO2001074780A8 Chemical complex comprising a pyridine carboxy derivative and an h2 histamine receptor antagonist |
| 05/30/2002 | WO2001074431A3 Dispensing devices and liquid formulations |
| 05/30/2002 | WO2001073094A3 Novel sperm-dna complexes for genetically modifying non-human animals |
| 05/30/2002 | WO2001068679A3 Peptides targeting specifically tumor-derived endothelial cells |
| 05/30/2002 | WO2001062296A3 Non-aqueous injectable formulations for extended release of somatotropin |
| 05/30/2002 | WO2001050994A8 Topical medicated bioadhesive compositions and methods of use and preparation thereof |
| 05/30/2002 | WO2001037781A8 A stable aqueous dispersion of nutrients |
| 05/30/2002 | WO2000076489A3 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits |
| 05/30/2002 | WO2000060953A3 Methods for stabilizing liquid nutritional products and products so stabilized |
| 05/30/2002 | US20020065411 Starch |
| 05/30/2002 | US20020065399 Aerosolized polypeptide for use in treatment of lung disorders lungs |
| 05/30/2002 | US20020065397 Protecting therapeutic compositions from host-mediated inactivation |
| 05/30/2002 | US20020065326 Patient oxygenation using stabilized fluorocarbon emulsions |
| 05/30/2002 | US20020065310 Method for treatment of tumors using nordihydroguaiaretic acid derivatives |
| 05/30/2002 | US20020065301 Paroxetine compositions and processes for making the same |
| 05/30/2002 | US20020065299 Administering for therapy of mitochondria medited disease |
| 05/30/2002 | US20020065298 Mitochondria protecting agents for treating mitochondria associated diseases |
| 05/30/2002 | US20020065264 Heterocylic leaving group containing -o-Het, or -s-Het, wherein Heterocyclic rings selected from pyridine, pyrole, furan, pyrimidine or proline derivatives |
| 05/30/2002 | US20020065263 Formulation |
| 05/30/2002 | US20020065255 Disodium salt of active delivery agents (drugs) form solvates with ethanol and hydrates with water; greater efficacy for delivering active agents than monosodium salt |
| 05/30/2002 | US20020065245 Sweetener |
| 05/30/2002 | US20020065241 A recombinant polynucleotide of first polynucleotides coding an antigenic peptide and are operatively linked to each other to enhance translation of the polynucleotides to the peptides and binding to MHC; cancer vaccine |
| 05/30/2002 | US20020065216 Novel method of diagnosing and treating gliomas |
| 05/30/2002 | US20020065213 Increasing the duration of expression of a delivered gene in target cells by delivering a gene encoding a cellular retention activity and nuclear binding sequence to target cells before or during gene of interest delivery |
| 05/30/2002 | US20020064862 Preventing viral replication in cells; obtain cells, incubate with viricide, monitor cells for reduced viral activity |
| 05/30/2002 | US20020064829 Human tumor necrosis factor delta and epsilon |
| 05/30/2002 | US20020064790 Generating nucleotide sequence binding ligand; obtain ligandthat binds to nucleotide sequence, monitor binding activity of particle and sequences, recover ligands that utilizes reduced energy to bind sequences compare to wild type |
| 05/30/2002 | US20020064566 Neutral to mildly alkaline; preventing and/or treating certain inflammatory diseases and/or degenerative diseases and/or certain viral diseases in a mammal |
| 05/30/2002 | US20020064565 Treating an eye infections; cleansing a contact lens in place on an eye |
| 05/30/2002 | US20020064563 Core particles which are coated with a taste mask coating to provide coated particles which can be sprinkled onto food to ease administration to patients who have difficulty swallowing tablets or capsules |
| 05/30/2002 | US20020064562 Granulates compacted together into a tablet form together with an extra-granular lubricant; especially amoxycillin plus clavulanic acid, and crosslinked polyvinylpyrrolidone or sodium starch glycolate intra-granular disintegrant |
| 05/30/2002 | US20020064561 Quick release compositions |
| 05/30/2002 | US20020064560 Hydrophobic and/or hydrophilic active agents and a polymeric emulsifier. |
| 05/30/2002 | US20020064554 Radiation sensitive liposomes |
| 05/30/2002 | US20020064547 Liquid polymeric compositions for controlled release of bioactive substances |
| 05/30/2002 | US20020064546 Degradable poly(ethylene glycol) hydrogels with controlled half-life and precursors therefor |
| 05/30/2002 | US20020064536 Immobilizing a mammal by administering the toxin with a polysaccharide stabilizer, nonimmunogenic; use after surgery such as hip displasia or to recover from leg injuries in domestic animals |
| 05/30/2002 | US20020064529 Method to reduce the physiologic effects of drugs on mammals |
| 05/30/2002 | US20020064525 Anti-IgE vaccines |
| 05/30/2002 | US20020064524 Formulation for topical non-invasive application in vivo |
| 05/30/2002 | US20020064520 Targeted artificial gene delivery |
| 05/30/2002 | US20020064516 Pharmaceutical compositions comprising TGF-beta |
| 05/30/2002 | US20020064514 Preparing material which comprises ionic polysaccharide and block polymer; placing material in contact with biological tissue; cross-linking to form gel |
| 05/30/2002 | US20020064513 For therapy of eye infections such as conjunctivitis, blepharitis, keratitis sicca etc and to provide intraocular treatment through the cornea for diseases such as glaucoma or uveitis |
| 05/30/2002 | US20020064512 May be used for medical indications, such as an implantable or injectable endoprostheses for mammoplastic reconstruction, implantable or injectable endoprostheses for treating (reflux) oesophagitis, and for body contouring of various body parts |
| 05/30/2002 | US20020064505 Oral anti-odor compositions |
| 05/30/2002 | US20020064503 Administering dose of mixture of lipid crystals comprising surfactant and spreading agnet as aerosol through an external airway of a mammal for enhancing mammalian eustachian tube lumen patency and pressure equalization performance |
| 05/30/2002 | CA2725716A1 Method of making 5, 10, 15, 20-tetrakis(carboxyphenyl) porphine solutions and compositions thereof |
| 05/30/2002 | CA2541946A1 Freeze-dried pantoprazole preparation and pantoprazole injection |
| 05/30/2002 | CA2429649A1 Drugs and foods improving the quality of life and process for producing the same |
| 05/30/2002 | CA2429516A1 As-needed administration of tricyclic and other non-sri antidepressant drugs to treat premature ejaculation |
| 05/30/2002 | CA2429313A1 Novel sulfonamide-substituted pyrazolopyridine derivatives |
| 05/30/2002 | CA2429310A1 Repinotan kit |
| 05/30/2002 | CA2427340A1 Cyp1b1 nucleic acids and methods of use |
| 05/30/2002 | CA2427334A1 Methods and compositions for the treatment of diseases of the eye |
| 05/30/2002 | CA2327208A1 Methods of increasing distribution of therapeutic agents |
| 05/29/2002 | EP1208855A1 Novel embolizing compositions |
| 05/29/2002 | EP1208850A1 Pastes with the sustained release of osteogenesis promoter |
| 05/29/2002 | EP1208848A1 Stable lactase compositions |
| 05/29/2002 | EP1208846A2 Non-aqueous polar aprotic peptide formulations |
| 05/29/2002 | EP1208218A2 Methods and compositions for delivery of pharmaceutical agents |
| 05/29/2002 | EP1208212A1 Fibrin sealant as a transfection/transformation vehicle for gene therapy |
| 05/29/2002 | EP1208143A1 Film coatings and film coating compositions based on polyvinyl alcohol |
| 05/29/2002 | EP1208140A1 Rapidly decomposing chitosan-based pellets |
| 05/29/2002 | EP1208133A1 Copolymers for the transfer of nucleic acids to the cell |
| 05/29/2002 | EP1208086A1 Benzamide formulation with histone deacetylase inhibitor activity |
| 05/29/2002 | EP1208005A1 Temperature-sensitive polymer/nanoshell composites for photothermally modulated drug delivery |
| 05/29/2002 | EP1207912A1 Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis |
| 05/29/2002 | EP1207910A2 Improved container composition for diagnostic agents |
| 05/29/2002 | EP1207909A2 Method for coupling molecules |
| 05/29/2002 | EP1207908A1 Method of treating body insect infestation |